Navigation Links
Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure,Reduction During Important Early Morning Period When Most Adverse,Cardiovascular Events Occur

on, which
is a counter-reaction of the body potentially decreasing the efficacy of current drug therapy1. In contrast to small molecule inhibitors, which display large variations in serum drug levels throughout the day, the vaccine-induced anti-angiotensin II antibodies were found to decline with a half-life of about 4 months. This may lead to a practically continuous inhibition of angiotensin II for weeks, which may in part account for the minor reactive rise observed in plasma renin concentration, and to the potent effect of the vaccine in early morning hours, as is further explained in the quote of Dr. Müller below.

A further important finding of the study is the dependence of efficacy on both the dose of the vaccine and the levels of induced anti-angiotensin II antibodies. Two doses of the vaccine, 100 ?g and 300 ?g, were tested in the trial. The induced anti-angiotensin antibody levels were significantly higher at the 300 ?g than at the 100 ?g dose (p=0.0098). Accordingly, blood pressure reduction was much larger and only significant at the 300 ?g dose (p=0.0498). Efficacy was thus driven by a longlasting, although reversible antibody response. Dr. Philipp Müller, EVP Clinical Development at Cytos Biotechnology comments on the study results:

“These data highlight a very important new aspect of the vaccine CYT006-AngQb, namely its exceptionally good control of the early morning blood pressure. So far, inhibition of the reninangiotensin system has been studied clinically only with small molecule inhibitors, which all produce a daily pattern of peaks and troughs in drug levels. Here, a trough in drug levels coincides with a natural rise of the blood pressure in early morning hours. The combination of these effects may lead to insufficient control of the early morning blood pressure surge. An intervention with a different pharmacokinetic profile like the vaccine approach, which avoids daily peaks and troughs in drug l
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
2. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
3. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
4. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
5. Gilead Announces Presentation of Long-Term Data for Ambrisentan, a Potential Treatment for Patients With Pulmonary Arterial Hypertension
6. Hypertension Education Foundation Survey Results Announced At American Society For Hypertension Annual Meeting Suggests Improved Control Of High Blood Pressure, But Misconceptions Still Exist
7. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension
8. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
9. King Pharmaceuticals Announces Plan to Present Results from Phase III Clinical Trial Evaluating ALTACE as Monotherapy and in Combination with Hydrochlorothiazide at the American Society of Hypertension Annual Meeting
10. Landmark Findings From ECLIPSE Program Show Improved Control of Perioperative Hypertension Reduces Risk of Death In Cardiac Surgery
11. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
Post Your Comments:
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... addition of the "Global Pharma US & ... Optimization Plays Major Role In Shaping Up Business ... their offering. Strategy Diversification Divested: ... healthy Cash position- Will accelerate Next wave of ...
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 ... a leading global specialty biopharmaceutical company, and Ikaria, Inc. ... have entered into a definitive agreement under which a ... Madison Dearborn -led investor group in a transaction ... to customary closing conditions, the parties expect the transaction ...
(Date:3/5/2015)... Hitachi Medical Systems Europe ... *    at ECR 2015 - the open ... a benchmark for patient-centric care. The new features of ... optimizing workflow management and costs. OASIS demonstrates the high ... imaging in Neurology, Orthopaedics, Paediatrics, Oncology, Vascular and General ...
Breaking Medicine Technology:Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 2Hitachi Medical Systems Europe Launches the New Generation of OASIS*- The World's Most Powerful Open High-Field 1.2T MRI - A New Level in Patient-Centric Care 3
(Date:3/5/2015)... 05, 2015 TCS Healthcare Technologies (TCS), ... the population health management arena, is pleased to announce ... software, ACUITY Advanced Care™ (ACUITY) version 7.20. The session ... and the advantages of automation. , The webinar, scheduled ... be led by Jeff Frater, RN, BSN, Director of ...
(Date:3/5/2015)... PA (PRWEB) March 05, 2015 ... leader in healthcare communications and education, announced today ... (AMP), the nation’s only medical conference designed ... limb ischemia and lower limb amputation due to ... growing family of innovative, evidence-based publications and CME ...
(Date:3/5/2015)... Los Angeles, Calif. (PRWEB) March 05, 2015 ... company and the leader in the natural products coffee ... Coffee at Natural Products Expo West in Anaheim, Calif. ... Califia’s home café concept, Califia Café, which democratizes the ... drinkers all the ingredients they need to become their ...
(Date:3/5/2015)... Frisco, TX (PRWEB) March 05, 2015 ... Convention Center in Fort Worth, Texas April 9-11th ... and wellness company providing personalized nutrition. IDLife ... core product, IDNutrition. This customized approach to ... research that begins with a free HIPAA compliant ...
(Date:3/5/2015)... March 05, 2015 For PASCHA Chocolate, ... most essential ingredients, the robust flavor of the cacao ... PASCHA Chocolate is free from peanuts, nuts, dairy, ... PASCHA's offering March 6th- 8th at Expo West., ... PASCHA Chocolate has broken new ground with their New ...
Breaking Medicine News(10 mins):Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 2Health News:Complimentary Webinar to Explore Enhanced Version of Premier Case Management Software 3Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 2Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 3Health News:Califia Farms Personalizes At-Home Coffee Experience with the Launch of Concentrated Cold Brew Coffee 4Health News:IDLife Partners John C. Maxwell and Troy Aikman speaking at IDRevolution in Fort Worth, TX April 9th-11th, 2015 2Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2
... WOODCLIFF LAKE, N.J., Dec. 12 Par Pharmaceutical Companies, Inc. ... Veronica A. Lubatkin, executive vice president and chief financial officer, ... , , Lawrence A. ... vice president of finance and will assume the role of ...
... September 8, 2008, TooBusyWorking was launched as a next-generation ... openings from all major employers onto a single Web ... than CareerBuilder, HotJobs, Nurse.com and Monster combined. , ... large number of job openings, each listing on TooBusyWorking ...
... can be achieved. A supplement published in Malaria ... many aspects of the research agenda for global malaria ... progress that has been made in the development of ... prevention. Elimination requires a different vaccine strategy, since success ...
... Terumo Corporation and Terumo,s,subsidiary, Terumo Cardiovascular Systems ... agreement to settle all outstanding litigation with,Maquet Cardiovascular, ... lawsuits pending,in which each claims the other has ... and devices used in endoscopic vessel harvesting. ...
... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS, NASDAQ: DDSS ... of the Toronto Stock Exchange, today commented on the ... is not aware of any reason for the recent ... Fee Act (PDUFA) action date for its once-daily formulation ...
... To protect the security of online file access from Internet fraud, ... its existing program Vetted QuickBase. , ... Raleigh, NC ... further protects its online file access from web fraud ...
Cached Medicine News:Health News:Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer 2Health News:Malaria Journal supplement evaluates steps toward elimination 2Health News:Labopharm Comments on Recent Trading Activity 2Health News:To Further Combat Internet Fraud, Heightened Security Levels are Implemented by Vetted International 2Health News:To Further Combat Internet Fraud, Heightened Security Levels are Implemented by Vetted International 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: